diagnosis capabilities Articles
-
InfraScan Inc. Announces Issuance of US Patents for Brain Diagnosis
Latest patents expand near infrared platform capabilities related to trauma and stroke diagnosis InfraScan, a medical device firm specializing in brain injury and stroke diagnostic products, announced today the issuance by the US Patent Office of three additional patents that cover internal bleeding, brain trauma and stroke detection technologies. The first patent for invention number US ...
-
A Closer Look at Reporter Lentiviral Particles: Tool for Biomedical Research
Introduction For years, scientists have leveraged the brilliant potentialities of genetic science to explore how cells function and interact in living organisms. Among the numerous tools employed are "reporter systems," which use a visible marker to track gene expression, protein interactions, and other vital biological processes. One such system employs reporter lentiviral particles, using the ...
-
A breath screen for active tuberculosis at the point-of-care
Tuberculosis (TB) is on the rise, and traditional technologies are not up to the task of containing this fast-spreading disease. But a fast, robust, and low-cost optical system is enabling point-of-care testing Driven by various social factors, a number of “old” diseases have recently reemerged to significantly threaten world health. Of particular concern is the increase in ...
-
Comparison Between Illumina and Nanopore Sequencing Technologies
What is Illumina Sequencing? Illumina sequencing is a second-generation sequencing technology that has become a powerful tool for genomics research. The method uses reversible dye terminator technology to detect the sequence of a DNA molecule. The process begins by fragmenting the DNA sample into short fragments, typically 100-150 base pairs (bp) in length. These fragments are then ligated to a ...
By CD Genomics
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you